Why is Indoco Remedies Ltd ?
1
Weak Long Term Fundamental Strength with a -36.71% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.69 times
- The company has been able to generate a Return on Equity (avg) of 7.83% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 14 consecutive quarters
- DEBT-EQUITY RATIO(HY) Highest at 1.16 times
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.67 times
- INTEREST(Q) Highest at Rs 45.92 cr
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -29.01% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Indoco Remedies for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Indoco Remedies
-29.01%
-0.66
44.01%
Sensex
-10.21%
-0.78
13.06%
Quality key factors
Factor
Value
Sales Growth (5y)
8.25%
EBIT Growth (5y)
-36.71%
EBIT to Interest (avg)
6.02
Debt to EBITDA (avg)
4.43
Net Debt to Equity (avg)
1.13
Sales to Capital Employed (avg)
1.08
Tax Ratio
7.33%
Dividend Payout Ratio
14.04%
Pledged Shares
0
Institutional Holding
19.09%
ROCE (avg)
10.05%
ROE (avg)
7.83%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
2.02
EV to EBIT
192.39
EV to EBITDA
20.83
EV to Capital Employed
1.48
EV to Sales
1.60
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
0.77%
ROE (Latest)
-9.82%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
Technical Movement
2What is working for the Company
PBDIT(Q)
Highest at Rs 49.71 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 10.45%
-13What is not working for the Company
DEBT-EQUITY RATIO(HY)
Highest at 1.16 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.67 times
INTEREST(Q)
Highest at Rs 45.92 cr
Loading Valuation Snapshot...
Here's what is working for Indoco Remedies
Operating Profit (PBDIT) - Quarterly
Highest at Rs 49.71 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 10.45%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Here's what is not working for Indoco Remedies
Interest - Quarterly
At Rs 45.92 cr has Grown at 79.10%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debt-Equity Ratio - Half Yearly
Highest at 1.16 times and Grown
each half year in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest - Quarterly
Highest at Rs 45.92 cr
in the last five quarters and Increased by 79.10 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debtors Turnover Ratio- Half Yearly
Lowest at 3.67 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio






